Applied Molecular Therapeutics is committed to developing novel, oral biological therapeutics to treat severe autoimmune, metabolic and inflammatory diseases. To achieve this, the company is leveraging its propriety technology platform to create oral therapeutics that harness naturally occurring transport and targeting mechanisms to cross the protective barrier of the intestinal epithelium (IE). Once across the IE, the therapeutics gain privileged access to the immune system, creating the potential for therapeutics payloads to act directly at the point of origin of immune dysregulation and restore immune homeostasis. 

Applied Molecular Transport Inc.

Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, metabolic and inflammatory diseases.

Applied Molecular Transport Inc. (AMTI) : Buy or Sell